Logo image of GORV

LAZYDAYS HOLDINGS INC (GORV) Stock Fundamental Analysis

USA - NASDAQ:GORV - US52110H2094 - Common Stock

2.1 USD
-0.12 (-5.41%)
Last: 10/16/2025, 6:53:09 PM
2.1 USD
0 (0%)
After Hours: 10/16/2025, 6:53:09 PM
Fundamental Rating

2

Overall GORV gets a fundamental rating of 2 out of 10. We evaluated GORV against 120 industry peers in the Specialty Retail industry. Both the profitability and financial health of GORV have multiple concerns. GORV has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year GORV has reported negative net income.
GORV had a positive operating cash flow in the past year.
In multiple years GORV reported negative net income over the last 5 years.
In multiple years GORV reported negative operating cash flow during the last 5 years.
GORV Yearly Net Income VS EBIT VS OCF VS FCFGORV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -35.22%, GORV is doing worse than 89.17% of the companies in the same industry.
GORV's Return On Equity of -270.11% is on the low side compared to the rest of the industry. GORV is outperformed by 77.50% of its industry peers.
Industry RankSector Rank
ROA -35.22%
ROE -270.11%
ROIC N/A
ROA(3y)-10.85%
ROA(5y)-3.93%
ROE(3y)-96.04%
ROE(5y)-50.53%
ROIC(3y)N/A
ROIC(5y)N/A
GORV Yearly ROA, ROE, ROICGORV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0 0 0 0 0 0 0 0 0 0

1.3 Margins

Looking at the Gross Margin, with a value of 23.31%, GORV is doing worse than 75.00% of the companies in the same industry.
In the last couple of years the Gross Margin of GORV has declined.
GORV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.14%
GM growth 5Y-2.08%
GORV Yearly Profit, Operating, Gross MarginsGORV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

More info and screens

0

2. Health

2.1 Basic Checks

GORV does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GORV has more shares outstanding
The number of shares outstanding for GORV has been increased compared to 5 years ago.
The debt/assets ratio for GORV is higher compared to a year ago.
GORV Yearly Shares OutstandingGORV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
GORV Yearly Total Debt VS Total AssetsGORV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

GORV has an Altman-Z score of 0.71. This is a bad value and indicates that GORV is not financially healthy and even has some risk of bankruptcy.
GORV has a Altman-Z score of 0.71. This is in the lower half of the industry: GORV underperforms 75.00% of its industry peers.
A Debt/Equity ratio of 3.77 is on the high side and indicates that GORV has dependencies on debt financing.
With a Debt to Equity ratio value of 3.77, GORV is not doing good in the industry: 78.33% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 3.77
Debt/FCF N/A
Altman-Z 0.71
ROIC/WACCN/A
WACC6.89%
GORV Yearly LT Debt VS Equity VS FCFGORV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

A Current Ratio of 0.91 indicates that GORV may have some problems paying its short term obligations.
GORV has a worse Current ratio (0.91) than 77.50% of its industry peers.
GORV has a Quick Ratio of 0.91. This is a bad value and indicates that GORV is not financially healthy enough and could expect problems in meeting its short term obligations.
GORV has a Quick ratio of 0.23. This is amonst the worse of the industry: GORV underperforms 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.23
GORV Yearly Current Assets VS Current LiabilitesGORV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for GORV have decreased strongly by -5061.11% in the last year.
The Revenue for GORV has decreased by -33.26% in the past year. This is quite bad
The Revenue has been growing slightly by 6.21% on average over the past years.
EPS 1Y (TTM)-5061.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-107.42%
Revenue 1Y (TTM)-33.26%
Revenue growth 3Y-10.97%
Revenue growth 5Y6.21%
Sales Q2Q%-44.99%

3.2 Future

Based on estimates for the next years, GORV will show a very strong growth in Earnings Per Share. The EPS will grow by 41.55% on average per year.
Based on estimates for the next years, GORV will show a very strong growth in Revenue. The Revenue will grow by 22.74% on average per year.
EPS Next Y97.15%
EPS Next 2Y41.55%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.13%
Revenue Next 2Y13.1%
Revenue Next 3Y22.74%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GORV Yearly Revenue VS EstimatesGORV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
GORV Yearly EPS VS EstimatesGORV Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 50 -50 100

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GORV. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 6.86, which indicates a rather cheap valuation of GORV.
Based on the Price/Forward Earnings ratio, GORV is valued cheaply inside the industry as 94.17% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.85, GORV is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 6.86
GORV Price Earnings VS Forward Price EarningsGORV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GORV Per share dataGORV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100 150

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as GORV's earnings are expected to grow with 41.55% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.55%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GORV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LAZYDAYS HOLDINGS INC

NASDAQ:GORV (10/16/2025, 6:53:09 PM)

After market: 2.1 0 (0%)

2.1

-0.12 (-5.41%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-13 2025-08-13
Earnings (Next)11-17 2025-11-17
Inst Owners89.17%
Inst Owner ChangeN/A
Ins Owners0.41%
Ins Owner Change0%
Market Cap7.85M
Analysts82.86
Price TargetN/A
Short Float %1.45%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.86
P/S 0.01
P/FCF N/A
P/OCF 19.78
P/B 0.14
P/tB 0.5
EV/EBITDA N/A
EPS(TTM)-83.61
EYN/A
EPS(NY)0.31
Fwd EY14.57%
FCF(TTM)-1.54
FCFYN/A
OCF(TTM)0.11
OCFY5.05%
SpS176.31
BVpS14.96
TBVpS4.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -35.22%
ROE -270.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.31%
FCFM N/A
ROA(3y)-10.85%
ROA(5y)-3.93%
ROE(3y)-96.04%
ROE(5y)-50.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.14%
GM growth 5Y-2.08%
F-Score5
Asset Turnover1.54
Health
Industry RankSector Rank
Debt/Equity 3.77
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 33.85%
Cap/Sales 0.93%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.23
Altman-Z 0.71
F-Score5
WACC6.89%
ROIC/WACCN/A
Cap/Depr(3y)281.4%
Cap/Depr(5y)231.34%
Cap/Sales(3y)4.66%
Cap/Sales(5y)3.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5061.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-107.42%
EPS Next Y97.15%
EPS Next 2Y41.55%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-33.26%
Revenue growth 3Y-10.97%
Revenue growth 5Y6.21%
Sales Q2Q%-44.99%
Revenue Next Year6.13%
Revenue Next 2Y13.1%
Revenue Next 3Y22.74%
Revenue Next 5YN/A
EBIT growth 1Y-17.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year116.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y94.41%
FCF growth 3YN/A
FCF growth 5Y27.91%
OCF growth 1Y101.34%
OCF growth 3Y223%
OCF growth 5Y19.39%